NASDAQ · EBACU
European Biotech Acquisition Corp.
Financial Services · Shell Companies
$11.30
Up+$0.40 (+3.67%)
Updated Sep 11, 2026, 6:57 PM
SID Score
—
Composite research score
Smart Money
—
Institutional and insider signal
- Market cap
- 181.22M
- P/E ratio
- 40.73
- Dividend yield
- 0.00%
- 52-week range
- — – —
- Volume
- 5.71K
- Avg. volume
- 1.56K
Price performance
EBACU price history
1M range · 0 trading sessions · Daily adjusted prices
EBACU does not have enough price history for the selected period.
Data unavailable
The requested market data was not found.
Latest EBACU news
The latest Smart Investors Daily articles mentioning EBACU.
Stock researchCompany · Overview
EBACU research
Overview
Company profile and research snapshot.
Company profile
European Biotech Acquisition Corp. does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. European Biotech Acquisition Corp. was incorporated in 2021 and is based in Amsterdam, the Netherlands.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- —
- Average target
- —
- Implied upside
- —
- Analysts
- —
News briefing
No generated briefing is available yet.
AI research layers
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
